0RCQNicox S.A.

LSE · GB · Healthcare · Biotechnology · nicox.com

0.3825EUR-0.65%Mkt Cap: —P/E: —3d ago

Nicox S.A., together with its subsidiaries, operates as an ophthalmology company in France and internationally. It develops solutions to preserving vision and improve eye health. The company's lead product candidate is N…

Key Statistics

Company

Market Cap—

Enterprise Value32.57M $

Revenue (TTM)18.23M $

Gross Profit7.11M $

Net Income (TTM)-2.62M $

Revenue/Share0.2272 USD

Last Price0.3825 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees10

CountryGB

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA4.51

EV/Revenue1.79

P/S—

P/B5.62

EPS (TTM)-1.17

EPS (Forward)—

52W Range

0.380544% of range0.3850

52W High0.3850 EUR

52W Low0.3805 EUR

Profitability

Gross Margin38.99%

Oper. Margin77.28%

EBITDA Margin39.58%

Profit Margin-14.39%

ROE-51.16%

ROA23.81%

Growth

Revenue Growth751.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF—

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt-4.07M $

Net Debt/EBITDA-0.56

Balance Sheet

Debt/Equity6.71

Current Ratio4.17

Quick Ratio3.00

Book Value/Sh0.0680 EUR

Cash/Share0.0470 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 EUR

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split0.2:1

Split DateDec 3, 2015

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.29.59M

Float85.07M

Insiders5.14%

Institutions1.60%

Technical

SMA 500.4110 (-6.9%)

SMA 2000.4858 (-21.3%)

Beta0.51

S&P 52W Chg19.18%

Avg Vol (30d)13.43K

Avg Vol (10d)22

Technical Indicators

RSI (14)51.1

MACD0.0018

MACD Signal0.0017

MACD Hist.+0.0001

BB Upper0.3972 EUR

BB Middle0.3800 EUR

BB Lower0.3629 EUR

BB Width9.02%

ATR (14)0.0086 EUR

Vol Ratio (20d)0.24x

0RCQNicox S.A.

Industry Peers

Key Statistics